Latest News of CNTX
Context Therapeutics Inc.'s (NASDAQ:CNTX) top owners are individual investors with 52% stake, while 30% is held by private equity firms
By Yahoo! Finance |
3 months ago
Ownership data of Context Therapeutics Inc. reveals that individual investors own 52%, private equity firms own 30%, and institutional investors hold a significant stake. Analyst forecasts and ownersh...
CNTX Stock Price | Context Therapeutics Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch
By MarketWatch |
4 months ago
Context Therapeutics, Inc. is focused on developing innovative treatments for hormone-driven breast and gynecological cancers. Their lead candidate, ONA-XR, aims to be a complete antagonist of the pro...